Babette Pettersen

Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY.

Allianz Capital Partners GmbH (ACP) is part of the private equity arm and a wholly-owned subsidiary of Allianz Alternative Assets Holding GmbH which in turn is a subsidiary of Allianz SE (FR: ALV; NYSE: AZ), a global leader in insurance and financial services. ACP was established in 1998 and is headquartered in Munich. The firm specializes in direct equity investment in unlisted companies. Their fellow subsidiary APEP-Allianz Private Equity Partners is primarily involved in indirect investments through private equity funds of funds. ACP invests capital exclusively on behalf of the life and non-life insurance companies of the Allianz Group.

Dow Silicones Corp. engages in the provision of silicones products and solutions. Its silicon-based materials are used in products and applications of sectors including electronics, automotive, construction, textiles, and healthcare. The company was founded in 1943 and is headquartered in Midland, MI.

Univation Technologies LLC manufactures chemical products for polyethylene production. It offers Operations training, technology and performance support, Operations improvement, product enhancement, and APC+ services. The company was founded in 1997 and is headquartered in Houston, TX.

XALT Energy LLC engages in the provision of energy storage solutions. It offers lithium-ion cells which are prototype electrodes. The firm provides storage solutions for commercial transportation, stationary storage and industrial and defense applications. The company was founded in 2009 and is headquartered in Midland, MI.

Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France.

By Design Ltd. owns & operates clothing and footwear stores. The company was founded in 1980 and is headquartered in Manchester, GB.

Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Mycogen LLC manufactures and sells agricultural products. The company was founded by Andrew C. Barnes and David H. Rammler in 1982 and is headquartered in Indianapolis, IN.

Part of UBE Corp., Advanced Electrolyte Technologies LLC is a company that manufactures and distributes electrolytes for lithium-ion batteries. The company is based in Troy, MI. Advanced Electrolyte Technologies was acquired by UBE Corp. from The Dow Chemical Co. on December 22, 2014.

Part of Dow, Inc., Dow Europe SA is a company that manufactures and sells chemicals, plastics, and industrial and agricultural products. The company is based in Midland, MI.

Part of Dow, Inc., Dow Europe GmbH is a Swiss materials science company that provides innovative and sustainable solutions for customers in packaging, infrastructure, and consumer care. The company is based in Horgen, Switzerland. Dow offers a portfolio of polyethylene solutions that provide excellent performance and processability for a wide range of applications. The company works closely with manufacturers to make chemical manufacturing, industrial operations, and 3D printing practices more sustainable and efficient. Dow is committed to making their website easy, enjoyable, and effective for their customers.

The U.S.-India Business Council operates as a business advocacy organization. The private company is based in Washington. The CEO of the American company is Joseph Gilmour.

DowAksa Ileri Kompozit Malzemeler Sanayi Ltd Sti engages in the manufacture and sales of carbon fiber for industrial use. It offers carbon fiber solutions for energy, infrastructure, and transportation markets. The company was founded in June 2012 and is headquartered in Istanbul, Turkey.

South Pole Holding AG is a Swiss company that develops and implements emission reduction projects and strategies to help companies, governments, and organizations achieve their sustainability goals. The company is based in Zurich, CH, and has a global presence of subsidiaries in several regions. The company offers innovative solutions to mitigate risk and turn climate action into long-term business opportunities. The company also operates a range of action platforms that bring public and private stakeholders together to facilitate the exchange of expertise and formulate action on sustainability and climate change. South Pole Holding was founded in 2006 by Christoph Grobbel, Renat Heuberger, Marco Hirsbrunner, and Renat Heuberger has been the CEO since then.

Dow AgroSciences LLC engages in the provision of agrochemical and biotechnology solutions. It offers pest management and biotechnology products to improve the quality of the food supply and contribute to health. The company was founded in 1989 and is headquartered in Indianapolis, IN.

DowAksa Advanced Composites Holdings BV is a Dutch company that provides market-leading solutions to enhance optics, improve cost efficiency, and increase compliance for pulp and paper applications. The joint venture company is based in Terneuzen, Netherlands. The company also offers silicone solutions that can help increase equipment reliability and protect system integrity for energy production. The company was founded in 2012.

EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France.

Biocleave Ltd. develops and sells microbial technology for the production of renewable chemicals and biofuels. It also provides biobutanol and other C4 chemical products. The firm also engages in microbiology and metabolic engineering through fermentation and commercial production scale. Its products include biobutanol chemicals and fuel, acetone, and butyric acid. The company was founded by Edward M. Green in 2003 and is headquartered in Abingdon, the United Kingdom.

Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France.

Actimis Pharmaceuticals, Inc. provides pharmaceutical research and development services. it focuses on the development of small therapeutics for respiratory and inflammatory disorders. The company was founded by Kevin B. Bacon in November 2004 and is headquartered in San Diego, CA.

Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo.

Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California.

NapaJen Pharma, Inc. develops drug delivery technology solutions through cellular transport pathways. Its products include lead platform and drug delivery. The firm specializes in the development of novel drug delivery systems by utilizing natural transport pathways whose cells are used to move molecular cargo into themselves and across internal compartments. The company was founded by Dr. Kazuo Sakurai and Hironori Ando in December 2004 and is headquartered in Burlingame, CA.

Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan.

Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.

Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million.